Furoxone_Swine_Mix
Category
Furoxone_Swine_Mix Brand names, Furoxone_Swine_Mix Analogs
Furoxone_Swine_Mix Brand Names Mixture
No information avaliable
Furoxone_Swine_Mix Chemical_Formula
C8H7N3O5
Furoxone_Swine_Mix RX_link
http://www.rxlist.com/cgi/generic2/furazol.htm
Furoxone_Swine_Mix fda sheet
Furoxone_Swine_Mix msds (material safety sheet)
Furoxone_Swine_Mix Synthesis Reference
No information avaliable
Furoxone_Swine_Mix Molecular Weight
225.158 g/mol
Furoxone_Swine_Mix Melting Point
255 oC
Furoxone_Swine_Mix H2O Solubility
40 mg/L
Furoxone_Swine_Mix State
Solid
Furoxone_Swine_Mix LogP
0.691
Furoxone_Swine_Mix Dosage Forms
Tablets; Liquid
Furoxone_Swine_Mix Indication
For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.
Furoxone_Swine_Mix Pharmacology
Furoxone has a broad antibacterial spectrum covering the majority of gastrointestinal tract pathogens including E. coli, staphylococci, Salmonella, Shigella, Proteus, Aerobacter aerogenes, Vibrio cholerae and Giardia lamblia. Its bactericidal activity is based upon its interference with DNA replication and protein production; this antimicrobial action minimizes the development of resistant organisms.
Furoxone_Swine_Mix Absorption
Radiolabeled drug studies indicate that furazolidone is well absorbed following oral administration
Furoxone_Swine_Mix Toxicity
Reactions to Furoxone have been reported including a fall in blood pressure, urticaria, fever, arthralgia, and a vesicular morbilliform rash. Other adverse effects can include a brown discoloration of the urine; hemolysis can occur in G6PDH-deficient patients. The drug has a monoamine oxidase (MAO) inhibitory effect and should never be given concurrently to individuals already taking MAO inhibitors.
Furoxone_Swine_Mix Patient Information
No information avaliable
Furoxone_Swine_Mix Organisms Affected
Microbes (bacteria, parasites)
